MENU
SER
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Serina Therapeutics (SER) Ownership - Who owns Serina Therapeutics?
Profile
Industry
N/A
Address
601 Genome Way
Phone
+1 256 327-0566
Employees
N/A
Web
https://www.serinatherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
57.57M
P/E Ratio
38.75
Total Cash
3.19M
Projected Growth
N/A
Total Debt
11.47M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.34
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SER
Capitalization
57.6M
P/E Ratio
38.75
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
3.19M
Total Cash/Share
0.34
Total Debt
11.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
-13.77M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
0.40
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
2.37M
Shares Outstanding - Current
9.39M
Total Liabilities
21.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
1144.156
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
601 Genome Way
Phone
+1 256 327-0566
Employees
N/A
Web
https://www.serinatherapeutics.com